These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36595209)

  • 1. Role and Clinical Significance of Monocarboxylate Transporter 8 (MCT8) During Pregnancy.
    Thomas J; Sairoz ; Jose A; Poojari VG; Shetty S; K SP; Prabhu R V K; Rao M
    Reprod Sci; 2023 Jun; 30(6):1758-1769. PubMed ID: 36595209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
    Morte B; Gil-Ibañez P; Heuer H; Bernal J
    Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
    Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
    Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Groeneweg S; Kersseboom S; van den Berge A; Dolcetta-Capuzzo A; van Geest FS; van Heerebeek REA; Arjona FJ; Meima ME; Peeters RP; Visser WE; Visser TJ
    Thyroid; 2019 Oct; 29(10):1499-1510. PubMed ID: 31436139
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of action of exogenously administered T3 on the fetal rat brain despite expression of the monocarboxylate transporter 8.
    Grijota-Martínez C; Díez D; Morreale de Escobar G; Bernal J; Morte B
    Endocrinology; 2011 Apr; 152(4):1713-21. PubMed ID: 21303950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency.
    Liao XH; Avalos P; Shelest O; Ofan R; Shilo M; Bresee C; Likhite S; Vit JP; Heuer H; Kaspar B; Meyer K; Dumitrescu AM; Refetoff S; Svendsen CN; Vatine GD
    Thyroid; 2022 Jul; 32(7):849-859. PubMed ID: 35350867
    [No Abstract]   [Full Text] [Related]  

  • 7. Prenatal Treatment of Thyroid Hormone Cell Membrane Transport Defect Caused by
    Refetoff S; Pappa T; Williams MK; Matheus MG; Liao XH; Hansen K; Nicol L; Pierce M; Blasco PA; Wiebers Jensen M; Bernal J; Weiss RE; Dumitrescu AM; LaFranchi S
    Thyroid; 2021 May; 31(5):713-720. PubMed ID: 32746752
    [No Abstract]   [Full Text] [Related]  

  • 8. Allan-Herndon-Dudley syndrome in Hong Kong: Implication for newborn screening.
    Yiu RS; Ling TK; Ko CH; Poon SW; Poon GW; Wong FC; Law CY; Iwayama H; Lam CW
    Clin Chim Acta; 2023 Nov; 551():117621. PubMed ID: 37925810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of an LC-MS/MS methodology for the quantification of thyroid hormones in dko MCT8/OATP1C1 mouse brain.
    De Angelis M; Maity-Kumar G; Schriever SC; Kozlova EV; Müller TD; Pfluger PT; Curras-Collazo MC; Schramm KW
    J Pharm Biomed Anal; 2022 Nov; 221():115038. PubMed ID: 36152487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of Reverse Triiodothyronine Level and the Triiodothyronine to Reverse Triiodothyronine Ratio in Dried Blood Spot Samples at Birth May Facilitate Early Detection of Monocarboxylate Transporter 8 Deficiency.
    Iwayama H; Kakita H; Iwasa M; Adachi S; Takano K; Kikuchi M; Fujisawa Y; Osaka H; Yamada Y; Okumura A; Hirani K; Weiss RE; Refetoff S
    Thyroid; 2021 Sep; 31(9):1316-1321. PubMed ID: 34049438
    [No Abstract]   [Full Text] [Related]  

  • 11. Disorder of thyroid hormone transport into the tissues.
    Groeneweg S; Visser WE; Visser TJ
    Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):241-253. PubMed ID: 28648511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution.
    Kersseboom S; Kremers GJ; Friesema EC; Visser WE; Klootwijk W; Peeters RP; Visser TJ
    Mol Endocrinol; 2013 May; 27(5):801-13. PubMed ID: 23550058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8.
    Kinne A; Kleinau G; Hoefig CS; Grüters A; Köhrle J; Krause G; Schweizer U
    J Biol Chem; 2010 Sep; 285(36):28054-63. PubMed ID: 20628049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovascular unit disruption and blood-brain barrier leakage in MCT8 deficiency.
    Guillén-Yunta M; Valcárcel-Hernández V; García-Aldea Á; Soria G; García-Verdugo JM; Montero-Pedrazuela A; Guadaño-Ferraz A
    Fluids Barriers CNS; 2023 Nov; 20(1):79. PubMed ID: 37924081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter.
    Friesema EC; Ganguly S; Abdalla A; Manning Fox JE; Halestrap AP; Visser TJ
    J Biol Chem; 2003 Oct; 278(41):40128-35. PubMed ID: 12871948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome.
    Maity-Kumar G; Ständer L; DeAngelis M; Lee S; Molenaar A; Becker L; Garrett L; Amerie OV; Hoelter SM; Wurst W; Fuchs H; Feuchtinger A; Gailus-Durner V; Garcia-Caceres C; Othman AE; Brockmann C; Schöffling VI; Beiser K; Krude H; Mroz PA; Hofmann S; Tuckermann J; DiMarchi RD; Hrabe de Angelis M; Tschöp MH; Pfluger PT; Müller TD
    Mol Metab; 2022 Dec; 66():101616. PubMed ID: 36270613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Inhibitors Based on Molecular Docking: Thyroid Hormone Transmembrane Transporter MCT8 as a Target.
    Shaji D
    Curr Drug Discov Technol; 2021; 18(1):105-112. PubMed ID: 31774046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Administration of the CNS-Selective Sobetirome Prodrug Sob-AM2 Exerts Thyromimetic Effects in Murine MCT8-Deficient Fetuses.
    Valcárcel-Hernández V; Guillén-Yunta M; Scanlan TS; Bárez-López S; Guadaño-Ferraz A
    Thyroid; 2023 May; 33(5):632-640. PubMed ID: 36792926
    [No Abstract]   [Full Text] [Related]  

  • 19. TRIAC Treatment Improves Impaired Brain Network Function and White Matter Loss in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice.
    Reinwald JR; Weber-Fahr W; Cosa-Linan A; Becker R; Sack M; Falfan-Melgoza C; Gass N; Braun U; Clemm von Hohenberg C; Chen J; Mayerl S; Muente TF; Heuer H; Sartorius A
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.